10-Panel Drug Screen..........$50.00


The 10-Panel drug screen is an all inclusive, point of use screening test for quick detection of Cocaine (COC), Amphetamine (AMP), Methamphetamine (M-AMP), Tetrahydrocannabinol (THC), Methadone (MTD), Opiates (OPI), Phencyclidine (PCP), Barbiturates (BAR), Benzodiazepines (BZD) and Tricyclic Antidepressant (TCA) in human urine.


SYMBOL  TARGET DRUG        CONC.
THCMARIJUANA             50 ng/ml
COCCOCAINE          300 ng/ml
PCPPHENCYCLIDINE       25 ng/ml
MOROPIATES   2000 ng/ml
METMETHAMPHETAMINE        1000 ng/ml
MTDMETHADONE     300 ng/ml
AMPAMPHETAMINE         1000 ng/ml
BARBARBITURATES         300 ng/ml
BZOBENZODIAZEPINES    300 ng/ml
TCATRICYCLIC ANTIDEPRESSANT   1000 ng/ml


CBSP provides leading edge medical laboratory tests and services for our valued clients through a national network of primary clinical laboratories and specialized centers of excellence.  With scientific expertise in esoteric testing, genomics and clinical and anatomic pathology, CBSP’s network of  laboratories perform more than one million tests on approximately 400,00 samples each day.  Our network of labs have over 80 years of combined service with over 2000 patient service centers, approximately 150 rapid response laboratories and 30-plus regional laboratories.

ALL CBSP Drug Tests are reviewed by a Medical Review Officer (MRO), a licensed physician who is qualified to determine if there is a legitimate explanation for a particular test result.

For more information, please contact CBSP, LLC. at (978) 887-2071 or email us at cbsp@comcast.net


*********************************************************************************************

As a privately owned company, CBSP is not limited to using certain vendors for any of our background screening data.  This is critical to the depth and breadth of our data.  We at CBSP have the freedom to research, test, evaluate and choose the vendors we use.  This is important because not all vendors supply quality data of the highest integrity.   CBSP does not engage in business with any vendor until we conduct our own due diligence.